Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 70.75B | 70.75B | 73.14B | 64.31B | 55.17B | 55.01B |
Gross Profit | 17.79B | 17.79B | 16.23B | 13.63B | 11.72B | 13.32B |
EBITDA | 9.49B | 9.83B | 8.66B | 6.54B | 5.32B | 6.50B |
Net Income | 5.65B | 5.65B | 5.09B | 3.63B | 2.75B | 3.86B |
Balance Sheet | ||||||
Total Assets | 103.10B | 103.10B | 100.54B | 89.74B | 80.77B | 79.06B |
Cash, Cash Equivalents and Short-Term Investments | 24.50B | 24.50B | 24.04B | 22.33B | 23.36B | 22.91B |
Total Debt | 4.45B | 4.45B | 4.04B | 3.58B | 1.35B | 1.58B |
Total Liabilities | 22.44B | 22.44B | 24.70B | 21.09B | 17.02B | 17.50B |
Stockholders Equity | 77.28B | 77.28B | 72.81B | 65.89B | 61.41B | 59.36B |
Cash Flow | ||||||
Free Cash Flow | 1.53B | 1.53B | 2.35B | -2.13B | 1.83B | 3.06B |
Operating Cash Flow | 7.32B | 7.32B | 4.18B | 2.03B | 2.69B | 4.94B |
Investing Cash Flow | -5.55B | -5.55B | -1.83B | -4.12B | -819.00M | -1.75B |
Financing Cash Flow | -1.79B | -1.79B | -819.00M | 937.00M | -1.64B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥51.95B | 14.34 | 11.64% | 3.72% | 1.90% | 36.12% | |
74 Outperform | ¥64.95B | 15.63 | 9.13% | 2.76% | 0.52% | -8.88% | |
71 Outperform | ¥57.88B | 12.77 | 11.78% | 2.84% | 2.79% | -14.83% | |
71 Outperform | ¥60.20B | 12.80 | ― | 2.48% | -6.68% | -11.92% | |
69 Neutral | ¥58.75B | 13.50 | 11.79% | 2.72% | 2.55% | 1.34% | |
66 Neutral | ¥55.55B | 22.76 | 7.26% | 2.88% | 9.31% | -62.88% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Denyo Co., Ltd. reported a significant decline in its financial performance for the three months ending June 30, 2025, with net sales dropping by 15.7% and operating profit decreasing by 64.3% compared to the same period last year. Despite the downturn, the company maintains a strong equity ratio of 75.9%, and it has forecasted a slight recovery in net sales and profit for the full fiscal year ending March 31, 2026, indicating potential stabilization in its operations.